{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:44:15Z","timestamp":1792201455723,"version":"4.4.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Plast Surg"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Anabolic-androgenic steroids (AAS) are widely implicated in gynecomastia development. Surgery is the definitive treatment for cases persisting after cessation of AAS use. Currently, the relevance of AAS use to the surgical approach of gynecomastia has not been well explored. This study aims to compare patient characteristics, surgical outcomes, and surgical management of gynecomastia correction in AAS users versus nonusers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective cohort study was performed with patients who underwent bilateral gynecomastia reduction surgery between January 2005 and August 2015 by a single surgeon at an academic hospital. Demographic data, AAS usage details, operative documentation, and follow-up outcomes were reviewed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 964 cases were reviewed. Eleven percent (n = 105) of the patients had a history of AAS use. Compared with non-AAS users, AAS users were older at time of gynecomastia onset (15 years vs 13 years, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) and surgery (28 years vs 25 years, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). The AAS users had higher body mass index (27.3 kg\/m<jats:sup>2<\/jats:sup> vs 25.7 kg\/m<jats:sup>2<\/jats:sup>, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) and a greater proportion of patients self-identified as bodybuilders (40.0% vs 22.4%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.002). Although no difference was found in the excised bilateral mastectomy volume (92.1 cm<jats:sup>3<\/jats:sup> vs 76.4 cm<jats:sup>3<\/jats:sup>, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.20), The AAS users had significantly less lipoaspirate fat volume (250 mL vs 300 mL, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.005). No difference was found in total complication rates. However, AAS users had significantly more revision mastectomy surgeries (3.8% vs 1.1%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.02).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The unique breast composition of AAS users necessitates a surgical approach with meticulous intraoperative hemostasis and careful glandular excision to minimize recurrence and achieve comparable low complication rates.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sap.0000000000001850","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:10:50Z","timestamp":1556064650000},"page":"258-263","source":"Crossref","is-referenced-by-count":10,"title":["Anabolic-androgenic Steroid Use Among Gynecomastia Patients"],"prefix":"10.1097","volume":"83","author":[{"given":"Miliana","family":"Vojvodic","sequence":"first","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Department of Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang Zhou","family":"Xu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runting","family":"Cai","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lissa","family":"Roy","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Department of Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Craig","family":"Fielding","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Department of Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,4,23]]},"reference":[{"key":"bib1-20230923","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2165\/00007256-200838060-00005","article-title":"Anabolic steroid use: patterns of use and detection of doping","volume":"38","year":"2008","journal-title":"Sports Med"},{"key":"bib2-20230923","first-page":"315","article-title":"Aromatase and gynecomastia","volume":"6","year":"1999","journal-title":"Endocr Relat Cancer"},{"key":"bib3-20230923","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.fertnstert.2014.02.002","article-title":"Anabolic steroid-induced hypogonadism: diagnosis and treatment","volume":"101","year":"2014","journal-title":"Fertil Steril"},{"key":"bib4-20230923","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1056\/NEJMcp070677","article-title":"Gynecomastia","volume":"357","year":"2007","journal-title":"N Engl J Med"},{"key":"bib5-20230923","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/phar.1138","article-title":"Drug-induced gynecomastia","volume":"32","year":"2012","journal-title":"Pharmacotherapy"},{"key":"bib6-20230923","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00006534-200101000-00039","article-title":"Management of gynecomastia due to use of anabolic steroids in bodybuilders","volume":"107","year":"2001","journal-title":"Plast Reconstr Surg"},{"key":"bib8-20230923","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00266-017-0943-7","article-title":"Surgical masculinization of the breast: clinical classification and surgical procedures","volume":"41","year":"2017","journal-title":"Aesthetic Plast Surg"},{"key":"bib9-20230923","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/PRS.0000000000000887","article-title":"Correction of gynecomastia in body builders and patients with good physique","volume":"135","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"bib10-20230923","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clindermatol.2006.09.012","article-title":"The hormonal regulation of cutaneous wound healing","volume":"25","year":"2007","journal-title":"Clin Dermatol"},{"key":"bib11-20230923","first-page":"226","article-title":"Reply to the comment on: Management of gynecomastia in patients with different body types: considerations on 312 consecutive treated cases","volume":"78","year":"2017","journal-title":"Ann Plast Surg"},{"key":"bib13-20230923","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/s-0035-1549053","article-title":"Trends in the surgical correction of gynecomastia","volume":"29","year":"2015","journal-title":"Semin Plast Surg"},{"key":"bib14-20230923","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00006534-198901000-00011","article-title":"Surgical treatment of gynecomastia in the body builder","volume":"83","year":"1989","journal-title":"Plast Reconstr Surg"},{"key":"bib15-20230923","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1177\/1090820X14526598","article-title":"Necessity of suction drains in gynecomastia surgery","volume":"34","year":"2014","journal-title":"Aesthet Surg J"},{"key":"bib16-20230923","doi-asserted-by":"crossref","first-page":"e854","DOI":"10.1097\/GOX.0000000000000844","article-title":"Anatomy of the gynecomastia tissue and its clinical significance","volume":"4","year":"2016","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"bib17-20230923","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666141210222725","article-title":"Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review","volume":"13","year":"2015","journal-title":"Curr Neuropharmacol"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000001850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T01:05:30Z","timestamp":1695431130000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000001850"}},"subtitle":["Prevalence and Relevance to Surgical Management"],"short-title":[],"issued":{"date-parts":[[2019,4,23]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0000000000001850","relation":{},"ISSN":["1536-3708","0148-7043"],"issn-type":[{"value":"1536-3708","type":"electronic"},{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,23]]}}}